Companies: 10,795·Total market cap: $144.5T
BioNTech SE

BioNTech SE

BNTXNASDAQHealthcare● Active
$88.08
$-1.51(-1.69%)
Market Cap$22.3B
P/E Ratio
52W High$124
52W Low$79.52
Overview

BioNTech SE(BNTX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BNTX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$2.76B$2.75B$3.82B$17.31B$18.98B
Cost of Revenue$0.62B$0.54B$0.60B$3.00B$2.91B
Gross Profit$2.14B$2.21B$3.22B$14.32B$16.07B
Gross Margin %(computed)77.64%80.32%84.29%82.70%84.66%
Operating Expenses
R&D Expenses$2.02B$2.25B$1.78B$1.54B$0.95B
G&A Expenses$0.59B$0.53B$0.49B$0.48B$0.28B
Total Operating Expenses$2.76B$3.52B$2.53B$1.67B$0.78B
Operating Income($0.62B)($1.31B)$0.69B$12.64B$15.28B
Operating Margin %(computed)-22.63%-47.77%18.08%73.03%80.54%
Interest Income$0.25B$0.00B$0.35B$0.05B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.02B$0.01B
Income Before Tax($1.01B)($0.68B)$1.19B$12.95B$15.05B
Income Tax Expense$0.08B($0.01B)$0.26B$3.52B$4.75B
Net Income($1.09B)($0.67B)$0.93B$9.43B$10.29B
Net Margin %(computed)-39.59%-24.18%24.36%54.50%54.24%
Per Share & EBITDA
EPS (Basic)$-4.51$-2.77$3.87$38.08$43.87
Wtd Avg Shares0.24B0.24B0.24B0.24B0.24B
EBITDA($0.26B)($0.37B)$1.38B$13.10B$15.00B
EBITDA Margin %(computed)-9.29%-13.34%36.07%75.65%79.06%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · EUR · B

深入了解BioNTech SE

关于BioNTech SE(BNTX)损益表

BioNTech SE(BNTX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BNTX实现营收$2.76B,毛利润$2.14B(毛利率77.64%),净利润($1.09B)(净利率-39.59%)。

常见问题

BNTX · 4 问

BioNTech SE(BNTX)2025财年营收为$2.76B,同比up0.2%。

BNTX revenueBNTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08